| Document Date: 2012-08-18 10:04:06
Open Document File Size: 23,60 KBShare Result on Facebook
City Mannheim / Stryker Biotech / / Company Denmark Eli Lilly & Co / Switzerland Eli Lilly & Co / Centocor BV / Chiron Corp / Genetics Institute Inc / T/A Roche Diagnostics / Amgen / Sweden Eli Lilly & Co / Austria Idec Pharmaceuticals Corp / Boehringer Ingelheim Pharma / Novartis Pharma / USA Aventis Pharma / Genzyme Corporation / Germany Genentech Inc / Interpharm Laboratories Ltd / Belgium Merck & Co Inc / Biologics Llc / Denmark Novartis Pharma / Genentech Inc / Pharmacia AB / Smithkline Beecham Biologicals SA / Schering-Plough / Biogen Inc / Conditions* Organisation Name Pharmacia AB / Novo Nordisk / Bayer Corp. / Hoffmann La Roche Inc / Austria Chugai Pharm Co / / Country Germany / Sweden / United States / Australia / Denmark / / MedicalCondition HBsAg Hepatitis B / Tumour necrosis / Hepatitis B / Recombinant Hepatitis B / alfa monoclonal antibody Beromun Tumour necrosis factor Tasonermin alpha / USA Saccharomyces cerevisiae Anti-tumour necrosis / Anti-tumour necrosis / Palivizumab Engerix-B Recombinant Hepatitis B / tumour / / Organization Therapeutic Goods Administration / / Person Israel Novo Nordisk / / Position Biotechnology General / / Product Herceptin / Zenapax / Refludan / Humatrope / Simulect / Aranesp / Cerezyme / Neupogen / Humalog / Gonal-F / Glucagon / Proleukin / Lantus / Remicade / Rebif / Avonex / Regranex / Pulmozyme / Norditropin / Eprex / Enbrel / Reopro / Saizen / Humulin / Genotropin / Roferon A / Intron A / Glucagen / / Technology alpha / Biotechnology / /
SocialTag |
Record of GMO and GM Product Dealings under Section 138 of the Gene Technology Act 2000 Dealings Involving GM products - therapeutics NB - All of these products have been approved for supply in Australia by the Therapeut